Toward Explainable Artificial Intelligence for Precision Pathology.

Journal: Annual review of pathology
Published Date:

Abstract

The rapid development of precision medicine in recent years has started to challenge diagnostic pathology with respect to its ability to analyze histological images and increasingly large molecular profiling data in a quantitative, integrative, and standardized way. Artificial intelligence (AI) and, more precisely, deep learning technologies have recently demonstrated the potential to facilitate complex data analysis tasks, including clinical, histological, and molecular data for disease classification; tissue biomarker quantification; and clinical outcome prediction. This review provides a general introduction to AI and describes recent developments with a focus on applications in diagnostic pathology and beyond. We explain limitations including the black-box character of conventional AI and describe solutions to make machine learning decisions more transparent with so-called explainable AI. The purpose of the review is to foster a mutual understanding of both the biomedical and the AI side. To that end, in addition to providing an overview of the relevant foundations in pathology and machine learning, we present worked-through examples for a better practical understanding of what AI can achieve and how it should be done.

Authors

  • Frederick Klauschen
    Pathologisches Institut, Ludwig-Maximilians-Universität München, Thalkirchner Str. 36, 80337, München, Deutschland. f.klauschen@lmu.de.
  • Jonas Dippel
    Machine Learning Group, Technische Universität Berlin, Berlin, Deutschland.
  • Philipp Keyl
    Institute of Pathology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität Berlin, Charitéplatz 1, 10117 Berlin, Germany.
  • Philipp Jurmeister
    Institute of Pathology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, 10117 Berlin, Germany.
  • Michael Bockmayr
    Institute of Pathology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, 10117 Berlin, Germany.
  • Andreas Mock
    Department of Translational Medical Oncology (TMO), National Center for Tumor Diseases (NCT) Heidelberg, German Cancer Research Center (DKFZ) Heidelberg, Im Neuenheimer Feld 460, 69120 Heidelberg, Germany.
  • Oliver Buchstab
    Institute of Pathology, Ludwig-Maximilians-Universität München, Munich, Germany; email: f.klauschen@lmu.de.
  • Maximilian Alber
    Berlin Big Data Center, Berlin Institute of Technology, Berlin, Germany.
  • Lukas Ruff
    Aignostics, Berlin, Germany.
  • Grégoire Montavon
    Machine Learning Group, Technische Universität Berlin, Berlin, Germany.
  • Klaus-Robert Müller
    Berlin Institute for the Foundations of Learning and Data (BIFOLD), Berlin, Deutschland.